BioCentury
ARTICLE | Company News

Genzyme to buy Focal

April 26, 2001 7:00 AM UTC

Genzyme Corp. will acquire the 78% of biomaterials company FOCL that it does not already own for 2.1 million shares of Genzyme Corp.'s Genzyme Biosurgery (GZBX) division, or $10 million based on GZBX'...